Is Sacubitril/Valsartan Able to Change the Timing for Implantation of Cardiac Devices in Heart Failure with Reduced Ejection Fraction?

Is Sacubitril/Valsartan Able to Change the Timing for Implantation of Cardiac Devices in Heart Failure with Reduced Ejection Fraction?

Aims: The aim of this study was to evaluate the impact of sacubitril/valsartan on left ventricular (LV) reverse remodeling, potentially modifying the timing for cardiac device implantation in heart failure with reduced ejection fraction (HFrEF), which has not been specifically addressed. Methods and...

Full description

Bibliographic Details
Main Authors: Marta Afonso Nogueira, Marisa Brochado, Inês Nabais, Élia Batista, Carla Matias, Gonçalo Proença
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Hearts
Subjects:
heart failure
left ventricular ejection fraction
sacubitril/valsartan
angiotensin receptor neprilysin inhibitor
cardiac devices
real-world evidence
Online Access:https://www.mdpi.com/2673-3846/3/3/12

Internet

https://www.mdpi.com/2673-3846/3/3/12

Similar Items